Company / Book Value per Share
Protalix BioTherapeutics, Inc. Book Value per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.57
FY2025
5-year range
-$2.023 / $0.57
FY2021-FY2025
Trend
+490.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share changed +491% YoY in FY2025, a notable deviation from the 9-year average annual change of -196%.
Based on SEC 10-K filings.
$0.57 in FY2025.
Improved from -$0.112 to $0.57 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, book value per share increased 490.6% year-over-year.
- Lowest book value per share in the period was in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.57 | +490.6% |
| FY2024 | -$0.146 | -30.0% |
| FY2023 | -$0.112 | +81.1% |
| FY2022 | -$0.593 | +70.7% |
| FY2021 | -$2.023 | +43.2% |
| FY2020 | -$3.564 | -79.5% |
| FY2019 | -$1.985 | -2366.5% |
| FY2017 | $0.088 | +115.7% |
| FY2016 | -$0.557 | -93.5% |
| FY2015 | -$0.288 | -702.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026